Tumors of the Prostate
Showing 1 - 25 of >10,000
Prostate Cancer, Physical Activity, Hypoxia Trial in Tromsø (Physical activity)
Terminated
- Prostate Cancer
- +2 more
- Physical activity
-
Tromsø, NorwayUniversity Hospital of North Norway
Jan 5, 2023
Prostate Cancer Trial in Rochester (Focal laser ablation of the prostate)
Recruiting
- Prostate Cancer
- Focal laser ablation of the prostate
-
Rochester, MinnesotaMayo Clinic in Minnesota
Jan 9, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023
Prostate Tumors Trial in Rochester (MR-guided cryoablation)
Recruiting
- Prostate Tumors
- MR-guided cryoablation
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 9, 2023
Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)
Recruiting
- Prostate Cancer
- +3 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)
Recruiting
- Prostate Cancer Metastatic
- Neuroendocrine Tumors
-
Duarte, California
- +2 more
Jan 18, 2023
Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- +4 more
-
Houston, TexasMD Anderson
Mar 27, 2023
Prostate Carcinoma Trial in Los Angeles (Digital Image Analysis, Radical Prostatectomy, Transrectal Ultrasound)
Active, not recruiting
- Prostate Carcinoma
- Digital Image Analysis
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 4, 2022
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
ABlative Radiotherapy (for) Unfavorable Prostate Tumors
Recruiting
- Prostate Cancer
-
Monza, MB, ItalyRadiation Oncology, ASST Monza (University of Milan Bicocca)
Jul 21, 2022
Prostate Cancer Recurrent, Solid Tumor, Adult Trial in Charleston (Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine,
Recruiting
- Prostate Cancer Recurrent
- Solid Tumor, Adult
- Hydroxychloroquine, Metformin, Sirolimus
- +3 more
-
Charleston, South CarolinaMedical University of South Carolina
Apr 4, 2022
MRI Workflow Alone in External Radiotherapy for Treatment of
Completed
- Prostate Cancer
- Brain Cancer
- Synthetic CT Scan
-
Angers, FranceInstitut de Cancerologie de L'Ouest
Mar 10, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Breast Cancer, Prostate Cancer, Advanced Solid Tumors Trial in Middletown, Harrison, New York (AZD5363, Enzalutamide,
Active, not recruiting
- Breast Cancer
- +2 more
- AZD5363
- +2 more
-
Middletown, New Jersey
- +2 more
Jul 5, 2022
Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)
Not yet recruiting
- Castrate Resistant Prostate Cancer
- NUT Carcinoma
- (no location specified)
Aug 3, 2022
Cancer Trial in Montreal (PSMA PET/CT)
Enrolling by invitation
- Cancer
- PSMA PET/CT
-
Montreal, Quebec, CanadaJewish General Hospital
Dec 9, 2021
Multimodal Machine Learning Characterization of Solid Tumors
Recruiting
- Adenocarcinoma of Prostate
- +5 more
- [18F]DCFPyL
- PET/MRI scanner
-
Boston, Massachusetts
- +1 more
Apr 4, 2022
Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE
Recruiting
- Neuroendocrine Tumors
- Prostate Cancer
- Single-Tracer FDG PET/CT Exam
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Dec 27, 2022